In Vitro Activity of Two Echinocandin Derivatives, LY303366 and MK-0991 (L-743,792), Against Clinical Isolates of Aspergillus, Fusarium, Rhizopus, and Other Filamentous Fungi
Authors:
- F MarcoFMF Marco
- S.A MesserSMS.A Messer
- R.N JonesRJR.N Jones
- 1 April 1998
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 30 (4) , 251-255
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)Antimicrobial Agents and Chemotherapy, 1997
- Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosisAntimicrobial Agents and Chemotherapy, 1997
- Treatment of murine disseminated candidiasis with L-743,872Antimicrobial Agents and Chemotherapy, 1997
- In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important moldsAntimicrobial Agents and Chemotherapy, 1997
- In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida speciesAntimicrobial Agents and Chemotherapy, 1997
- In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agentsAntimicrobial Agents and Chemotherapy, 1997
- Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungiJournal of Clinical Microbiology, 1997
- Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosisAntimicrobial Agents and Chemotherapy, 1995
- In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373Antimicrobial Agents and Chemotherapy, 1995
- ANTIBIOTICS THAT INHIBIT FUNGAL CELL WALL DEVELOPMENTAnnual Review of Microbiology, 1994